In Brief UNC Lineberger to establish $25M Center for Triple Negative Breast Cancer January 28, 2022Vol.48 No.04
Drugs & Targets FDA grants fast track designation for enobosarm in AR+ ER+ HER2- metastatic breast cancer January 14, 2022Vol.48 No.02
In Brief Roman Skoracki named director of Ohio State’s Stefanie Spielman Comprehensive Breast Center December 10, 2021Vol.47 No.45
In Brief Sharon Wilks joins NEXT Oncology’s phase I clinical investigation team December 10, 2021Vol.47 No.45
Clinical Roundup UK study identifies method of predicting treatment response in breast cancer December 10, 2021Vol.47 No.45
Clinical Roundup Researchers use genomics to match treatments to improved outcomes in metastatic breast cancer December 10, 2021Vol.47 No.45
Clinical Roundup Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy December 10, 2021Vol.47 No.45
Clinical Roundup Breast cancer patients with ER mutations may benefit from early switch to Faslodex/Ibrance December 10, 2021Vol.47 No.45
Clinical Roundup Black women more likely to develop lymphedema following breast cancer treatment than white women December 10, 2021Vol.47 No.45
Cancer History ProjectConversation with The Cancer LetterFree Patricia Ganz on how survivorship went from being an outlier to the mainstream November 19, 2021Vol.47 No.43By Alexandria Carolan
